Malignant Melanoma

Showing NaN - NaN of 21

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Malignant Melanoma Trial in Worldwide (Pembrolizumab, Lenvatinib, Placebo for lenvatinib)

Active, not recruiting
  • Malignant Melanoma
  • Pembrolizumab
  • +2 more
  • Los Angeles, California
  • +118 more
Aug 22, 2022

Malignant Melanoma Trial in Worldwide (UV1, Sargramostim, Ipilimumab)

Recruiting
  • Malignant Melanoma
  • UV1
  • +3 more
  • Phoenix, Arizona
  • +39 more
Aug 16, 2022

Malignant Melanoma Trial in Aurora (Oral Decitabine/Cedazuridine (DEC-C) in Combination with Nivolumab)

Recruiting
  • Malignant Melanoma
  • Oral Decitabine/Cedazuridine (DEC-C) in Combination with Nivolumab
  • Aurora, Colorado
    University of Colorado Hospital
May 25, 2022

Malignant Melanoma Trial in Worldwide (Atezolizumab, Cobimetinib)

Completed
  • Malignant Melanoma
  • Scottsdale, Arizona
  • +42 more
Nov 17, 2021

NSCLC, Urothelial Carcinoma, Malignant Melanoma Trial in Aurora, Lake Mary, Philadelphia (CAN04, Pembrolizumab)

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • +3 more
  • Aurora, Colorado
  • +2 more
Nov 17, 2020

Malignant Melanoma, Medullary Thyroid Cancer, Glioblastoma Trial in United States (Rovalpituzumab tesirine, Dexamethasone)

Terminated
  • Malignant Melanoma
  • +7 more
  • Gilbert, Arizona
  • +29 more
Sep 21, 2020

Malignant Melanoma Trial in Worldwide (Placebo, Vemurafenib, Cobimetinib)

Completed
  • Malignant Melanoma
  • Placebo
  • +2 more
  • Birmingham, Alabama
  • +155 more
Sep 14, 2020

Malignant Melanoma Trial in United States (Atezolizumab, Cobimetinib, Vemurafenib)

Completed
  • Malignant Melanoma
  • Los Angeles, California
  • +7 more
Jul 20, 2020

Malignant Melanoma Trial in Worldwide (ABI-007, Dacarbazine)

Completed
  • Malignant Melanoma
  • Birmingham, Alabama
  • +111 more
Oct 16, 2019

Malignant Melanoma Trial in Australia, United States (Cobimetinib, vemurafenib)

Completed
  • Malignant Melanoma
  • Los Angeles, California
  • +9 more
Jul 26, 2019

Malignant Melanoma Trial in Worldwide (Ipilimumab)

Terminated
  • Malignant Melanoma
  • Ipilimumab
  • Phoenix, Arizona
  • +31 more
Jul 31, 2017

Malignant Melanoma Trial in United States (Vemurafenib)

Terminated
  • Malignant Melanoma
  • Tucson, Arizona
  • +14 more
Apr 24, 2017

Malignant Melanoma Trial in Canada, United States (Nivolumab, Ipilimumab)

No longer available
  • Malignant Melanoma
  • Gilbert, Arizona
  • +65 more
Feb 6, 2017

Malignant Melanoma Trial in United States (RO5185426)

Completed
  • Malignant Melanoma
  • La Jolla, California
  • +9 more
Nov 1, 2016

Malignant Melanoma Trial in Worldwide (vemurafenib)

Terminated
  • Malignant Melanoma
  • Los Angeles, California
  • +25 more
Aug 25, 2016

Malignant Melanoma Trial in Worldwide (Vemurafenib, Dacarbazine)

Completed
  • Malignant Melanoma
  • Birmingham, Alabama
  • +110 more
Aug 19, 2016

Malignant Melanoma Trial in United States (RO5185426)

Completed
  • Malignant Melanoma
  • Tucson, Arizona
  • +27 more
Jul 12, 2016

Malignant Melanoma Trial in Worldwide (Vemurafenib)

Completed
  • Malignant Melanoma
  • Los Angeles, California
  • +32 more
Jun 20, 2016

Malignant Melanoma Trial in United States (imexon, DTIC)

Completed
  • Malignant Melanoma
  • Los Angeles, California
  • +10 more
Sep 14, 2010

Malignant Melanoma Trial in Worldwide (CancerVax vaccine (CANVAXIN))

Unknown status
  • Malignant Melanoma
  • CancerVax vaccine (CANVAXIN)
  • Tucson, Arizona
  • +79 more
Jun 23, 2005

Malignant Melanoma Trial in Worldwide (CancerVax vaccine (CANVAXIN))

Unknown status
  • Malignant Melanoma
  • CancerVax vaccine (CANVAXIN)
  • Tucson, Arizona
  • +76 more
Jun 23, 2005